CVS Health to split into two publicly traded companies by 2028, FT reports
CVS Health Corp (NYSE:CVS) is planning to split its retail pharmacy business from its insurance operations, potentially unwinding one of the U.S. healthcare industry’s largest vertical integration deals, the Financial Times reported on Tuesday, citing people familiar with the matter.
Under plans being discussed, CVS would spin off its roughly 9,000 drugstores into a separate publicly traded company, while insurer Aetna and pharmacy-benefit manager Caremark would remain together, the report said.
The retail pharmacy division is projected to generate about a third of CVS’s $417 billion in revenue this year, the FT reported.
The proposed restructuring would reverse CVS’s $78 billion acquisition of Aetna in 2018, amid mounting political pressure to separate pharmacy-benefit managers from pharmacies and insurers.
The company could announce the move alongside its third-quarter results, although the structure and timeline remain subject to change, the report said.
Should you invest $2,000 in CVS right now?
That’s one option. But ProPicks AI re-evaluates CVS alongside thousands of other companies every month, using 100+ financial metrics, and it may have found you a better stock.
ProPicks AI looks past headlines and Reddit to fundamentals, momentum and valuation. You get the rationale behind every pick, so you can check the logic before you act on it. Over three years, our strategies have returned 2.3X the S&P 500’s returns.
Find out whether CVS made this month’s lists, and which stocks in the same space did.
